Drug Product Development Suppliers Serving Germany

MerLion Pharmaceuticals is a biopharma company focusing on the research and development of drugs for the treatment of serious bacterial infections. MerLion - located in Berlin-Buch, Germany - manages the non-clinical and clinical development as well ...

As a global Contract Research Organization (CRO), headquartered in New York, USA, Alfa Chemistry has served the pharmaceutical and biotechnology industries for years. Today, Alfa Chemistry is specialized in organic chemistry, material chemistry, and ...

Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available, small molecule drugs known as allosteric modulators for neurological disorders. Allosteric ...

For more than 40 years, Agilent Technologies has been the leading provider of solutions for the detection, identification, and characterization of chemical and biological compounds. From environmental testing to semiconductor manufacturing, ...

Nanion combines trusted scientific support with exceptional instrumentation to accelerate successful drug development and scientific discoveries. Our broad range of applications and user-friendly assay solutions can be tailored to your needs to ...

Eutilex is Developing anti-tumor T cell therapy and antibody therapeutics based on its own proprietary immunotherapy technology We set a goal to be a leading company in anti-tumor immunotherapy markets through the technical innovation & early ...

ABX advanced biochemical compounds, established in 1997 and headquartered in Radeberg, Germany, leads the industry in radiopharmaceuticals focusing on positron emission tomography (PET) tracers. With a workforce of approximately 400 professionals, ...

Skyepharma is a key player in drug development and delivery of oral technologies serving the global pharmaceutical, biotech and consumer health industries. Since 1996, we help our clients to offer the best drug for the benefit of the patient. In ...

Txinno Bioscience is developing anti-cancer treatments focused on two intertwined aspects of physiology of tumor tissue. Tcino Bioscience Co., Ltd. has secured and built core platform technologies such as small molecule innovative anticancer drug ...

BCN Peptides is a European GMP API manufacturing company based in Barcelona. We are a privately owned CDMO based in Barcelona, completely focused on the GMP manufacture of Bioactive Peptides for pharmaceutical, veterinary and cosmetic applications. ...

We are an interdisciplinary team with a focus on research, translation, clinical development, manufacturing, and commercialization. Our passionate team is committed to provide safe and effective tumor therapy. We are supported by a strong scientific ...

MMIT, a Norstella company, focuses on enhancing market access for pharmaceutical companies by offering real-time data and insights as well as crucial commercial execution strategies. With decades of experience, MMIT has evolved from its origins as ...

Newcells offers expert disease modelling services using best in class in vitro platforms and supports drug development by providing robust data for regulatory submissions and the critical decision-making process. Newcells mission is to de-risk the ...

Advaita Bioinformatics develops bioinformatics data analysis tools with capabilities to integrate multi-‘omic’ data from a systems biology perspective. Our proprietary computational method, Impact Analysis, considers the type, function, position and ...

The drug discovery and development process is long and expensive with more failures than successes. At Certara, we anticipate and address your critical drug discovery and development risks and decisions using biosimulation, technology and services. ...

Virica was founded in 2018 based on a decade of research in the laboratory of Dr. Jean-Simon Diallo at the Ottawa Hospital Research Institute. Dr. Diallo was investigating novel oncolytic viral therapies (OVTs) and recognized the need for VSEs to ...

Founded in 2014, LCC is now established as one of the world’s most innovative CROs. We believe that curiosity driven by purpose leads to new ideas and faster progress. By offering improved access to 3D chemical space, we help to accelerate the ...

We are a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. We have more than a decade of experience contending with ...

Kalaris was founded by experienced leaders in ophthalmology drug development and commercialization to address a major unmet need in the treatment of retinal diseases. Existing therapies for retinal neovascular / exudative diseases have made great ...

We are a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of best-in-class novel nanomedicines that combine our proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ...